You don't get invited to speak at those things unless you have a reason. This technology will impact the insurance world, and future stem cell research could affect life expectancy, as ACTC is also working on stem cells that could repair a damaged heart. This would then affect the growing number of institutional investors buying up life insurance policies. The older they live, the less money they make. That's a whole different topic.